Neuronal Interferon Signaling Is Required for Protection against Herpes Simplex Virus Replication and Pathogenesis

English version České info

Herpes simplex virus type 1 (HSV-1) is a ubiquitous virus that can cause cold sores, blindness, and even death from encephalitis. There is no vaccine against HSV, and although antiviral drugs can control HSV-1, it persists because it establishes lifelong latent infections in neurons. Humans with deficiencies in innate immunity have significant problems controlling HSV infections. In this study we therefore sought to elucidate the role of neuronal innate immunity in the control of viral infection. Sensory neurons, in which HSV resides, have projection which that extend long distances to innervate the skin, the initial site of HSV infection. We found that neurons can respond to interferon beta, a molecule that strongly stimulates innate immunity and inhibits virus growth, at both the cell body and at the end of these long projections. Moreover, we found that this interferon response of neurons is critical for controlling HSV infection in vivo and that the interferon responses of non-neuronal cells are insufficient to provide protection. Our results have important implications for understanding how the nervous system defends itself against virus infections.

Vyšlo v časopise: Neuronal Interferon Signaling Is Required for Protection against Herpes Simplex Virus Replication and Pathogenesis. PLoS Pathog 11(7): e32767. doi:10.1371/journal.ppat.1005028
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1005028

Souhrn

Zdroje

1. Blyth WA, Harbour DA, Hill TJ. Pathogenesis of zosteriform spread of herpes simplex virus in the mouse. J Gen Virol. 1984;65 (Pt 9): 1477–1486. 6088680

2. Smith G. Herpesvirus transport to the nervous system and back again. Annu Rev Microbiol. 2012;66 : 153–176. doi: 10.1146/annurev-micro-092611-150051 22726218

3. Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA J Am Med Assoc. 2006;296 : 964–973.

4. Rowe AM, St Leger AJ, Jeon S, Dhaliwal DK, Knickelbein JE, Hendricks RL. Herpes keratitis. Prog Retin Eye Res. 2013;32 : 88–101. doi: 10.1016/j.preteyeres.2012.08.002 22944008

5. Whitley RJ, Gnann JW. Viral encephalitis: familiar infections and emerging pathogens. Lancet. 2002;359 : 507–513. 11853816

6. Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen IZ, Al-Jumaah S, et al. Impaired response to interferon-[alpha]/[beta] and lethal viral disease in human STAT1 deficiency. Nat Genet. 2003;33 : 388–391. 12590259

7. Leib DA, Harrison TE, Laslo KM, Machalek MA, Moorman NJ, Virgin HW. Interferons Regulate the Phenotype of Wild-type and Mutant Herpes Simplex Viruses In Vivo. J Exp Med. 1999;189 : 663–672. 9989981

8. Levy DE, Marié IJ, Durbin JE. Induction and function of type I and III interferon in response to viral infection. Curr Opin Virol. 2011;1 : 476–486. doi: 10.1016/j.coviro.2011.11.001 22323926

9. Conrady CD, Halford WP, Carr DJJ. Loss of the Type I Interferon Pathway Increases Vulnerability of Mice to Genital Herpes Simplex Virus 2 Infection. J Virol. 2011;85 : 1625–1633. doi: 10.1128/JVI.01715-10 21147921

10. Zhang S-Y, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science. 2007;317 : 1522–1527. 17872438

11. Paladino P, Mossman KL. Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res. 2009;29 : 599–607.

12. Chou J, Kern ER, Whitley RJ, Roizman B. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science. 1990;250 : 1262–1266. 2173860

13. Li Y, Zhang C, Chen X, Yu J, Wang Y, Yang Y, et al. ICP34.5 protein of herpes simplex virus facilitates the initiation of protein translation by bridging eukaryotic initiation factor 2alpha (eIF2alpha) and protein phosphatase 1. J Biol Chem. 2011;286 : 24785–24792. doi: 10.1074/jbc.M111.232439 21622569

14. Verpooten D, Ma Y, Hou S, Yan Z, He B. Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1. J Biol Chem. 2009;284 : 1097–1105. doi: 10.1074/jbc.M805905200 19010780

15. Gobeil PAM, Leib DA. Herpes Simplex Virus γ34.5 Interferes with Autophagosome Maturation and Antigen Presentation in Dendritic Cells. mBio. 2012;3: e00267–12. doi: 10.1128/mBio.00267-12 23073763

16. Orvedahl A, Alexander D, Tallóczy Z, Sun Q, Wei Y, Zhang W, et al. HSV-1 ICP34.5 Confers Neurovirulence by Targeting the Beclin 1 Autophagy Protein. Cell Host Microbe. 2007;1 : 23–35. 18005679

17. Rampling R, Cruickshank G, Papanastassiou V, Nicoll J, Hadley D, Brennan D, et al. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Ther. 2000;7 : 859–866. 10845724

18. Leib DA, Machalek MA, Williams BR, Silverman RH, Virgin HW. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc Natl Acad Sci U S A. 2000;97 : 6097–6101. 10801979

19. Thompson RL, Stevens JG. Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent. Virology. 1983;131 : 171–179. 6316649

20. Whitley RJ, Kern ER, Chatterjee S, Chou J, Roizman B. Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models. J Clin Invest. 1993;91 : 2837–2843. 8390490

21. Yordy B, Iijima N, Huttner A, Leib D, Iwasaki A. A neuron-specific role for autophagy in antiviral defense against herpes simplex virus. Cell Host Microbe. 2012;12 : 334–345. doi: 10.1016/j.chom.2012.07.013 22980330

22. Rosato PC, Leib DA. Intrinsic innate immunity fails to control herpes simplex and vesicular stomatitis virus replication in sensory neurons and fibroblasts. J Virol. 2014;

23. Cho H, Proll SC, Szretter KJ, Katze MG, Gale M Jr, Diamond MS. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat Med. 2013;

24. Daffis S, Samuel MA, Suthar MS, Gale M Jr, Diamond MS. Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol. 2008;82 : 10349–10358. doi: 10.1128/JVI.00935-08 18715906

25. Samuel MA, Diamond MS. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol. 2005;79 : 13350–13361. 16227257

26. Trottier MD Jr., Palian BM, Shoshkes Reiss C. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. Virology. 2005;333 : 215–225. 15721356

27. Low-Calle AM, Prada-Arismendy J, Castellanos JE. Study of interferon-β antiviral activity against Herpes simplex virus type 1 in neuron-enriched trigeminal ganglia cultures. Virus Res. 2014;180 : 49–58. doi: 10.1016/j.virusres.2013.12.022 24374267

28. De Regge N, Van Opdenbosch N, Nauwynck HJ, Efstathiou S, Favoreel HW. Interferon Alpha Induces Establishment of Alphaherpesvirus Latency in Sensory Neurons In Vitro. PLoS ONE. 2010;5: e13076. doi: 10.1371/journal.pone.0013076 20927329

29. Lafaille FG, Pessach IM, Zhang S-Y, Ciancanelli MJ, Herman M, Abhyankar A, et al. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature. 2012;491 : 769–773. doi: 10.1038/nature11583 23103873

30. Farmer JR, Altschaefl KM, O’Shea KS, Miller DJ. Activation of the type I interferon pathway is enhanced in response to human neuronal differentiation. PloS One. 2013;8: e58813. doi: 10.1371/journal.pone.0058813 23505563

31. Schultz KLW, Vernon PS, Griffin DE. Differentiation of Neurons Restricts Arbovirus Replication and Increases Expression of the Alpha Isoform of IRF-7. J Virol. 2015;89 : 48–60. doi: 10.1128/JVI.02394-14 25320290

32. Bertke AS, Swanson SM, Chen J, Imai Y, Kinchington PR, Margolis TP. A5-Positive Primary Sensory Neurons are Non-Permissive for Productive Infection with Herpes Simplex Virus 1 In Vitro. J Virol. 2011;

33. Campenot RB. Local control of neurite development by nerve growth factor. Proc Natl Acad Sci U S A. 1977;74 : 4516–4519. 270699

34. Curanović D, Ch’ng TH, Szpara M, Enquist L. Compartmented Neuron Cultures for Directional Infection by Alpha Herpesviruses. Curr Protoc Cell Biol Editor Board Juan Bonifacino Al. 2009;CHAPTER: Unit–26.4.

35. Lancaster KZ, Pfeiffer JK. Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response. PLoS Pathog. 2010;6: e1000791. doi: 10.1371/journal.ppat.1000791 20221252

36. Kawakami T, Hikawa N, Kusakabe T, Kano M, Bandou Y, Gotoh H, et al. Mechanism of inhibitory action of capsaicin on particulate axoplasmic transport in sensory neurons in culture. J Neurobiol. 1993;24 : 545–551. 7686960

37. Luker GD, Prior JL, Song J, Pica CM, Leib DA. Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J Virol. 2003;77 : 11082–11093. 14512556

38. Chopy D, Detje CN, Lafage M, Kalinke U, Lafon M. The type I interferon response bridles rabies virus infection and reduces pathogenicity. J Neurovirol. 2011;17 : 353–367. doi: 10.1007/s13365-011-0041-6 21805057

39. Detje CN, Meyer T, Schmidt H, Kreuz D, Rose JK, Bechmann I, et al. Local type I IFN receptor signaling protects against virus spread within the central nervous system. J Immunol Baltim Md 1950. 2009;182 : 2297–2304.

40. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell. 1990;60 : 585–595. 1689217

41. Summers BC, Margolis TP, Leib DA. Herpes Simplex Virus Type 1 Corneal Infection Results in Periocular Disease by Zosteriform Spread. J Virol. 2001;75 : 5069–5075. 11333887

42. Vikman K, Robertson B, Grant G, Liljeborg A, Kristensson K. Interferon-gamma receptors are expressed at synapses in the rat superficial dorsal horn and lateral spinal nucleus. J Neurocytol. 1998;27 : 749–759. 10640190

43. Liu T, Khanna KM, Carriere BN, Hendricks RL. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J Virol. 2001;75 : 11178–11184. 11602757

44. Li J, Hu S, Zhou L, Ye L, Wang X, Ho J, et al. Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons. Glia. 2011;59 : 58–67. doi: 10.1002/glia.21076 20878770

45. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol. 2006;80 : 4501–4509. 16611910

46. Ida-Hosonuma M, Iwasaki T, Yoshikawa T, Nagata N, Sato Y, Sata T, et al. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol. 2005;79 : 4460–4469. 15767446

47. Reinert LS, Harder L, Holm CK, Iversen MB, Horan KA, Dagnæs-Hansen F, et al. TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J Clin Invest. 2012;122 : 1368–1376. doi: 10.1172/JCI60893 22426207

48. Shimeld C, Dyson H, Lewkowicz-Moss S, Hill TJ, Blyth WA, Easty DL. Spread of HSV-1 to the mouse eye after inoculation in the skin of the snout requires an intact nerve supply to the inoculation site. Curr Eye Res. 1987;6 : 9–12. 3030659

49. Simmons A, Nash AA. Role of antibody in primary and recurrent herpes simplex virus infection. J Virol. 1985;53 : 944–948. 2983100

50. Heskel NS, Hanifin JM. “Recurrent herpes zoster”: an unproved entity? J Am Acad Dermatol. 1984;10 : 486–490. 6327783

51. Ng DCH, Lin BH, Lim CP, Huang G, Zhang T, Poli V, et al. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J Cell Biol. 2006;172 : 245–257. 16401721

52. Mohr A, Chatain N, Domoszlai T, Rinis N, Sommerauer M, Vogt M, et al. Dynamics and non-canonical aspects of JAK/STAT signalling. Eur J Cell Biol. 2012;91 : 524–532. doi: 10.1016/j.ejcb.2011.09.005 22018664

53. Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2015;1: CD002898. doi: 10.1002/14651858.CD002898.pub5 25879115

54. Harland J, Dunn P, Cameron E, Conner J, Brown SM. The herpes simplex virus (HSV) protein ICP34.5 is a virion component that forms a DNA-binding complex with proliferating cell nuclear antigen and HSV replication proteins. J Neurovirol. 2003;9 : 477–488. 12907392

55. Zaichick SV, Bohannon KP, Hughes A, Sollars PJ, Pickard GE, Smith GA. The herpesvirus VP1/2 protein is an effector of dynein-mediated capsid transport and neuroinvasion. Cell Host Microbe. 2013;13 : 193–203. doi: 10.1016/j.chom.2013.01.009 23414759

56. Schmeisser H, Bekisz J, Zoon KC. New Function of Type I IFN: Induction of Autophagy. J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res. 2014;

57. Hafezi W, Lorentzen EU, Eing BR, Müller M, King NJC, Klupp B, et al. Entry of Herpes Simplex Virus Type 1 (HSV-1) into the Distal Axons of Trigeminal Neurons Favors the Onset of Nonproductive, Silent Infection. PLoS Pathog. 2012;8: e1002679. doi: 10.1371/journal.ppat.1002679 22589716

58. Rader KA, Ackland-Berglund CE, Miller JK, Pepose JS, Leib DA. In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts. J Gen Virol. 1993;74 (Pt 9): 1859–1869. 8397283

59. Menachery VD, Pasieka TJ, Leib DA. Interferon regulatory factor 3-dependent pathways are critical for control of herpes simplex virus type 1 central nervous system infection. J Virol. 2010;84 : 9685–9694. doi: 10.1128/JVI.00706-10 20660188

60. Esen N, Tanga FY, DeLeo JA, Kielian T. Toll-like receptor 2 (TLR2) mediates astrocyte activation in response to the Gram-positive bacterium Staphylococcus aureus. J Neurochem. 2004;88 : 746–758. 14720224

61. Alexander DE, Ward SL, Mizushima N, Levine B, Leib DA. Analysis of the Role of Autophagy in Replication of Herpes Simplex Virus in Cell Culture. J Virol. 2007;81 : 12128–12134. 17855538

62. Brown SM, Ritchie DA, Subak-Sharpe JH. Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map. J Gen Virol. 1973;18 : 329–346. 4348796

63. Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, et al. The Role of IFN in Respiratory Syncytial Virus Pathogenesis. J Immunol. 2002;168 : 2944–2952. 11884466

64. Pasieka TJ, Collins L, O’Connor MA, Chen Y, Parker ZM, Berwin BL, et al. Bioluminescent Imaging Reveals Divergent Viral Pathogenesis in Two Strains of Stat1-Deficient Mice, and in αßγ Interferon Receptor-Deficient Mice. PloS One. 2011;6: e24018. doi: 10.1371/journal.pone.0024018 21915277

65. Wallner B, Leitner NR, Vielnascher RM, Kernbauer E, Kolbe T, Karaghiosoff M, et al. Generation of mice with a conditional Stat1 null allele. Transgenic Res. 2012;21 : 217–224. doi: 10.1007/s11248-011-9519-5 21553074

66. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet. 1999;23 : 99–103. 10471508

67. Dodd J, Jessell TM. Lactoseries carbohydrates specify subsets of dorsal root ganglion neurons projecting to the superficial dorsal horn of rat spinal cord. J Neurosci Off J Soc Neurosci. 1985;5 : 3278–3294.

68. Kramer MF, Coen DM. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J Virol. 1995;69 : 1389–1399. 7853471

69. Gierasch WW, Zimmerman DL, Ward SL, VanHeyningen TK, Romine JD, Leib DA. Construction and characterization of bacterial artificial chromosomes containing HSV-1 strains 17 and KOS. J Virol Methods. 2006;135 : 197–206. 16647145

70. Livak KJ, Schmittgen TD. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods. 2001;25 : 402–408. 11846609

71. Smith TJ, Ackland-Berglund CE, Leib DA. Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice. J Virol. 2000;74 : 3598–3604. 10729135

72. Hankenson FC, Ruskoski N, van Saun M, Ying G-S, Oh J, Fraser NW. Weight Loss and Reduced Body Temperature Determine Humane Endpoints in a Mouse Model of Ocular Herpesvirus Infection. J Am Assoc Lab Anim Sci JAALAS. 2013;52 : 277–285.